1. Home
  2. NSPR vs APYX Comparison

NSPR vs APYX Comparison

Compare NSPR & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • APYX
  • Stock Information
  • Founded
  • NSPR 2005
  • APYX 1982
  • Country
  • NSPR United States
  • APYX United States
  • Employees
  • NSPR N/A
  • APYX N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • APYX Medical/Dental Instruments
  • Sector
  • NSPR Health Care
  • APYX Health Care
  • Exchange
  • NSPR Nasdaq
  • APYX Nasdaq
  • Market Cap
  • NSPR 74.8M
  • APYX 85.0M
  • IPO Year
  • NSPR N/A
  • APYX 1987
  • Fundamental
  • Price
  • NSPR $2.38
  • APYX $2.09
  • Analyst Decision
  • NSPR Strong Buy
  • APYX Hold
  • Analyst Count
  • NSPR 2
  • APYX 2
  • Target Price
  • NSPR $4.50
  • APYX N/A
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • APYX 101.1K
  • Earning Date
  • NSPR 08-05-2025
  • APYX 08-07-2025
  • Dividend Yield
  • NSPR N/A
  • APYX N/A
  • EPS Growth
  • NSPR N/A
  • APYX N/A
  • EPS
  • NSPR N/A
  • APYX N/A
  • Revenue
  • NSPR $7,066,000.00
  • APYX $46,512,000.00
  • Revenue This Year
  • NSPR $4.85
  • APYX $6.03
  • Revenue Next Year
  • NSPR $113.47
  • APYX $4.96
  • P/E Ratio
  • NSPR N/A
  • APYX N/A
  • Revenue Growth
  • NSPR 7.60
  • APYX N/A
  • 52 Week Low
  • NSPR $1.99
  • APYX $0.76
  • 52 Week High
  • NSPR $3.80
  • APYX $2.73
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • APYX 49.86
  • Support Level
  • NSPR $2.35
  • APYX $1.82
  • Resistance Level
  • NSPR $2.52
  • APYX $2.70
  • Average True Range (ATR)
  • NSPR 0.14
  • APYX 0.19
  • MACD
  • NSPR -0.02
  • APYX -0.01
  • Stochastic Oscillator
  • NSPR 7.50
  • APYX 51.67

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: